The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...

Australia is set to get a new COVID vaccine in the next two weeks, but what variant is it targeting? And should we all still ...

Your agencies’ refusal to provide complete and unredacted responses and documents to my numerous oversight letters on the ...

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.

The latest health news highlights BridgeBio's new heart drug approved by the FDA, novel findings in breast cell research, ...

President-elect Donald Trump nominated his picks for Centers for Disease Control and prevention director, Food and Drug ...